Abbott Defends Glucose Monitor Patents In Sinocare Fight

By Hanna Vioque ( December 3, 2025, 5:20 PM GMT) -- Abbott has denied Sinocare's claims that its patents are invalid and asserted that the use of several screen features provided benefits to device users, accusing its rival once more of selling glucose monitors that infringe its intellectual property....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login